DK1805192T3 - Salte af isophosphoramidsennep og analoger deraf som antitumor-midler - Google Patents

Salte af isophosphoramidsennep og analoger deraf som antitumor-midler

Info

Publication number
DK1805192T3
DK1805192T3 DK05821125.1T DK05821125T DK1805192T3 DK 1805192 T3 DK1805192 T3 DK 1805192T3 DK 05821125 T DK05821125 T DK 05821125T DK 1805192 T3 DK1805192 T3 DK 1805192T3
Authority
DK
Denmark
Prior art keywords
isophosphoramide
snaps
analogs
salts
antitumor agents
Prior art date
Application number
DK05821125.1T
Other languages
Danish (da)
English (en)
Inventor
Lee Morgan
Original Assignee
Dekk Tec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tec Inc filed Critical Dekk Tec Inc
Application granted granted Critical
Publication of DK1805192T3 publication Critical patent/DK1805192T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/222—Amides of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05821125.1T 2004-10-25 2005-10-25 Salte af isophosphoramidsennep og analoger deraf som antitumor-midler DK1805192T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US67270705P 2005-04-18 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Publications (1)

Publication Number Publication Date
DK1805192T3 true DK1805192T3 (da) 2013-02-04

Family

ID=35788704

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05821125.1T DK1805192T3 (da) 2004-10-25 2005-10-25 Salte af isophosphoramidsennep og analoger deraf som antitumor-midler
DK10178422.1T DK2336140T3 (en) 2004-10-25 2005-10-25 Of isophosphoramide mustard salts and analogs thereof as antitumor agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10178422.1T DK2336140T3 (en) 2004-10-25 2005-10-25 Of isophosphoramide mustard salts and analogs thereof as antitumor agents

Country Status (17)

Country Link
US (4) US7678778B2 (https=)
EP (3) EP2336140B1 (https=)
JP (1) JP5336082B2 (https=)
KR (2) KR101292026B1 (https=)
CN (3) CN101087800B (https=)
AU (1) AU2005299385B2 (https=)
CA (1) CA2585125C (https=)
DK (2) DK1805192T3 (https=)
ES (2) ES2397165T3 (https=)
HK (1) HK1209752A1 (https=)
IL (3) IL182752A (https=)
NO (1) NO20072478L (https=)
NZ (2) NZ555323A (https=)
PL (1) PL1805192T3 (https=)
PT (1) PT1805192E (https=)
SI (1) SI1805192T1 (https=)
WO (1) WO2006047575A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336140B1 (en) 2004-10-25 2016-01-27 Dekk-Tec, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
MX2009010820A (es) * 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.
NZ601139A (en) * 2008-07-31 2014-02-28 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
AU2010218109B2 (en) 2009-02-24 2015-04-09 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
WO2017044453A1 (en) 2015-09-10 2017-03-16 Becton, Dickinson And Company Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
EP3565520B1 (en) 2017-01-06 2026-02-25 Palvella Therapeutics, Inc. Anhydrous compositions of mtor inhibitors and methods of use
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN209400423U (zh) 2017-09-21 2019-09-17 贝克顿·迪金森公司 横向流测定物、测定物读取器装置和包括其的系统
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
EP3856754A1 (en) * 2018-09-25 2021-08-04 The United States of America, as represented by the Secretary, Department of Health and Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (https=) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
ZA871260B (en) * 1986-02-22 1987-09-30 Asta Werke Ag Chem Fab Novel heterocyclic compounds having a 2-(2-(n,n-bis-(2-chloroethyl)-diamidophosphoryloxy)ethyl)radical
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
CA2130578A1 (en) 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
DE60007120T2 (de) 1999-05-24 2004-09-16 Southern Research Institute, Birmingham Isophosphoramide-senfgasanalogen und deren verwendung
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
GB2378948B (en) 2000-04-13 2004-11-10 Hsc Res Dev Lp Novel compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
EP2186811A1 (en) 2002-08-23 2010-05-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
EP2336140B1 (en) * 2004-10-25 2016-01-27 Dekk-Tec, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
MX2009010820A (es) 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.
NZ601139A (en) * 2008-07-31 2014-02-28 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Also Published As

Publication number Publication date
IL182752A (en) 2012-09-24
EP2336140A2 (en) 2011-06-22
WO2006047575A3 (en) 2006-08-10
US20060089333A1 (en) 2006-04-27
US7678778B2 (en) 2010-03-16
CA2585125A1 (en) 2006-05-04
AU2005299385B2 (en) 2011-06-16
KR101292026B1 (ko) 2013-08-01
IL211936A0 (en) 2011-05-31
IL182752A0 (en) 2007-07-24
JP5336082B2 (ja) 2013-11-06
HK1100945A1 (en) 2007-11-16
CN104558023A (zh) 2015-04-29
HK1209752A1 (en) 2016-04-08
DK2336140T3 (en) 2016-03-21
EP1805192A2 (en) 2007-07-11
US9346836B2 (en) 2016-05-24
CN103172662A (zh) 2013-06-26
ES2397165T3 (es) 2013-03-05
EP2336139A3 (en) 2012-01-04
US20150152125A1 (en) 2015-06-04
IL211935A0 (en) 2011-05-31
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
JP2008517949A (ja) 2008-05-29
PT1805192E (pt) 2013-01-23
EP2336140A3 (en) 2012-01-11
KR20130041384A (ko) 2013-04-24
US20080267945A1 (en) 2008-10-30
CA2585125C (en) 2014-04-22
EP2336139A2 (en) 2011-06-22
NZ589418A (en) 2012-03-30
AU2005299385A1 (en) 2006-05-04
IL211936A (en) 2012-12-31
ES2565929T3 (es) 2016-04-07
PL1805192T3 (pl) 2013-03-29
US20130149296A1 (en) 2013-06-13
KR20070121632A (ko) 2007-12-27
NO20072478L (no) 2007-06-25
NZ555323A (en) 2010-12-24
CN101087800B (zh) 2015-01-07
SI1805192T1 (sl) 2013-02-28
WO2006047575A2 (en) 2006-05-04
CN101087800A (zh) 2007-12-12
US8795659B2 (en) 2014-08-05
US8232262B2 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
DK1805192T3 (da) Salte af isophosphoramidsennep og analoger deraf som antitumor-midler
DK1781604T3 (da) Bis(thio-hydrazid-amid)-salte til behandling af cancere
DK1802579T3 (da) Derivater af 3-arylaminopyridin
EP1788874A4 (en) 5-AZACYTIDINE SALTS
DK3395338T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DE602005012267D1 (de) N von geräten
DK1778618T3 (da) Syntese af triethylentetraminer
CR9080A (es) Compuestos sulfonamida
DK1962830T3 (da) Azaindolhæmmere af aurorakinaser.
DK2039685T3 (da) Heterobicycliske forbindelser som P38-inhibitorer
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
DK2377869T3 (da) Syntese af Bortezomib
DK1664043T3 (da) Sammensætninger egnede som inhibitorer af proteinkinaser
DK1636190T3 (da) Stabilt krystal af 4-oxoquinolinforbindelse
DK1888595T3 (da) Spiro-oxindolforbindelser og deres anvendelser som terapeutiske midler
DK1797042T3 (da) Indozolonderivater som 11B-HSD1-inhibitorer
DE602006010546D1 (de) N-(pyridin-2-yl)sulfonamidderivate
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1830850T3 (da) Quinolin-derivater til behandling af latent tuberkulose
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK1708991T3 (da) Sulfonamid derivater til behandling af sygdomme
DE602005027308D1 (de) Stabile salze von olanzapin
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan